WASHINGTON: US pharmaceutical company Merck has entered into voluntary licensing agreements with seven generic manufacturers to produce low-cost versions of its experimental HIV prevention pill, Alimatravir. According to the company, the agreements will allow the drug to be provided at a low cost in 129 developing, low-income and middle-income countries, where a large number of The post Merck signs licensing deals for experimental HIV prevention pill appeared first on MM News.
GrowthPakistan brings you the latest news to keep an eye on Pakistan’s startup ecosystem. Business keeps you growing when you stay aware of your competitors' moves. GrowthPakistan offers Business, Tech, Global Tech, Global, Auto, and Startup News straight from industries all around the globe. This platform will help you identify upcoming opportunities not only in Pakistan but worldwide.
Email : growthpakistan@gmail.com
Whatsapp : +92320-9497079
© growthpakistan